Fulgent Genetics Inc (FLGT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 84,076 | 58,348 | 66,172 | 79,506 | 168,770 |
| Marketable Securities | 383,726 | 400,083 | 438,313 | 446,729 | 402,290 |
| Receivables | 49,277 | 34,809 | 43,549 | 52,749 | 104,159 |
| Other current assets | 32,776 | 35,049 | 32,689 | 48,889 | 21,395 |
| TOTAL | $549,855 | $528,289 | $580,723 | $627,873 | $696,614 |
| Non-Current Assets | |||||
| PPE Net | 85,265 | 87,556 | 79,083 | 81,353 | 81,807 |
| Investments And Advances | 383,659 | 388,383 | 366,833 | 326,648 | 346,946 |
| Intangibles | 286,333 | 288,443 | 291,819 | 293,670 | 208,166 |
| Other Non-Current Assets | 53,286 | 61,906 | 58,309 | 56,509 | 72,249 |
| TOTAL | $808,543 | $826,288 | $796,044 | $758,180 | $709,168 |
| Total Assets | $1,358,398 | $1,354,577 | $1,376,767 | $1,386,053 | $1,405,782 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 14,999 | 14,999 | 14,999 |
| Accounts payable and accrued liabilities | 15,772 | 20,607 | 22,080 | 23,093 | 14,481 |
| Accrued Expenses | 21,031 | 22,229 | 21,088 | 24,981 | 25,101 |
| Other current liabilities | 21,728 | 17,423 | 18,164 | 19,395 | 42,034 |
| TOTAL | $61,421 | $64,819 | $81,939 | $88,107 | $102,522 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 25,669 | 26,793 | 26,418 | 28,315 | 22,239 |
| TOTAL | $35,143 | $26,432 | $25,909 | $28,071 | $21,863 |
| Total Liabilities | $96,564 | $91,251 | $107,848 | $116,178 | $124,385 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 29,633 | 29,927 | 29,701 | 29,519 | 29,438 |
| Common Shares | 3 | 3 | 3 | 3 | 3 |
| Retained earnings | 761,324 | 774,431 | 785,660 | 801,000 | 824,832 |
| Other shareholders' equity | -13,755 | -17,183 | -12,725 | -17,713 | -21,252 |
| TOTAL | $1,261,834 | $1,263,326 | $1,268,919 | $1,269,875 | $1,281,397 |
| Total Liabilities And Equity | $1,358,398 | $1,354,577 | $1,376,767 | $1,386,053 | $1,405,782 |